These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 33005869)
1. Chalcones, stilbenes and ketones have anti-infective properties via inhibition of bacterial drug-efflux and consequential synergism with antimicrobial agents. Hellewell L; Bhakta S Access Microbiol; 2020; 2(4):acmi000105. PubMed ID: 33005869 [TBL] [Abstract][Full Text] [Related]
2. New Chalcone-Triazole Hybrids with Promising Antimicrobial Activity in Multidrug Resistance Strains. Pereira D; Durães F; Szemerédi N; Freitas-da-Silva J; Pinto E; Martins-da-Costa P; Pinto M; Correia-da-Silva M; Spengler G; Sousa E; Cidade H Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430768 [TBL] [Abstract][Full Text] [Related]
3. BDDE-Inspired Chalcone Derivatives to Fight Bacterial and Fungal Infections. Jesus A; Durães F; Szemerédi N; Freitas-Silva J; da Costa PM; Pinto E; Pinto M; Spengler G; Sousa E; Cidade H Mar Drugs; 2022 May; 20(5):. PubMed ID: 35621966 [TBL] [Abstract][Full Text] [Related]
4. Antibacterial activities and structure-activity relationships of a panel of 48 compounds from Kenyan plants against multidrug resistant phenotypes. Omosa LK; Midiwo JO; Mbaveng AT; Tankeo SB; Seukep JA; Voukeng IK; Dzotam JK; Isemeki J; Derese S; Omolle RA; Efferth T; Kuete V Springerplus; 2016; 5(1):901. PubMed ID: 27386347 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of a series of 2-napthamide derivatives as inhibitors of the drug efflux pump AcrB for the reversal of antimicrobial resistance. Wang Y; Mowla R; Guo L; Ogunniyi AD; Rahman T; De Barros Lopes MA; Ma S; Venter H Bioorg Med Chem Lett; 2017 Feb; 27(4):733-739. PubMed ID: 28129976 [TBL] [Abstract][Full Text] [Related]
6. Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis. Machado D; Pires D; Perdigão J; Couto I; Portugal I; Martins M; Amaral L; Anes E; Viveiros M PLoS One; 2016; 11(2):e0149326. PubMed ID: 26919135 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of bacterial efflux pumps: a new strategy to combat increasing antimicrobial agent resistance. Kaatz GW Expert Opin Emerg Drugs; 2002 Oct; 7(2):223-33. PubMed ID: 15989546 [TBL] [Abstract][Full Text] [Related]
8. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria]. Hasdemir U Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720 [TBL] [Abstract][Full Text] [Related]
9. Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria. Wang Y; Venter H; Ma S Curr Drug Targets; 2016; 17(6):702-19. PubMed ID: 26424403 [TBL] [Abstract][Full Text] [Related]
10. The AcrAB efflux pump confers self-resistance to stilbenes in Photorhabdus laumondii. Hadchity L; Houard J; Lanois A; Payelleville A; Nassar F; Gualtieri M; Givaudan A; Abi Khattar Z Res Microbiol; 2023; 174(7):104081. PubMed ID: 37196776 [TBL] [Abstract][Full Text] [Related]
15. Understanding efflux in Gram-negative bacteria: opportunities for drug discovery. Schweizer HP Expert Opin Drug Discov; 2012 Jul; 7(7):633-42. PubMed ID: 22607346 [TBL] [Abstract][Full Text] [Related]
17. Bacterial efflux pumps involved in multidrug resistance and their inhibitors: rejuvinating the antimicrobial chemotherapy. Bhardwaj AK; Mohanty P Recent Pat Antiinfect Drug Discov; 2012 Apr; 7(1):73-89. PubMed ID: 22353004 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of Multifunctional Hybrid Analogs for Stilbenes, Chalcones and Flavanones. Cagir A; Odaci B; Varol M; Akcok I; Okur O; Koparal AT Anticancer Agents Med Chem; 2018 Feb; 17(14):1915-1923. PubMed ID: 28554313 [TBL] [Abstract][Full Text] [Related]
19. [The importance of efflux systems in antibiotic resistance and efflux pump inhibitors in the management of resistance]. Aygül A Mikrobiyol Bul; 2015 Apr; 49(2):278-91. PubMed ID: 26167829 [TBL] [Abstract][Full Text] [Related]
20. Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use. Lomovskaya O; Bostian KA Biochem Pharmacol; 2006 Mar; 71(7):910-8. PubMed ID: 16427026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]